Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTYTVXF)

DTT Name Hyaluronic acid (HA)
Gene Name HA
DTT Type
Successful target
 [1]
UniProt ID
NOUNIPROTAC
TTD ID
T51038

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
2 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hyaluronidase (ovine) DMETWAU Resorption of radiopaque agents N.A. Approved [1]
Hylenex DMVAIH4 Solid tumour/cancer 2A00-2F9Z Approved [2]
------------------------------------------------------------------------------------

References

1 Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005 Oct;140(4):585-97.
2 Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discov. 2011 September; 1(4): 291-296.